EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

PAP Versus DIEP Flap Breast Reconstruction: Current Evidence and the Unresolved Question of Timing and Oncologic Safety—A Narrative Review

Maximilian Vlad Muntean, Radu Alexandru Ilieș, Vlad Alexandru Gâta iD, Ștefan Țîțu iD, Ioan Constantin Pop iD, Alex Victor Orădan iD, Gerald Gheorghe Filip, Roxana Pintican iD, Nicoleta Zenovia Antone iD, Patriciu Andrei Achimaș-Cadariu iD

Medical Sciences · 06.06.2026 · 14 (2) · 295

DOI: 10.3390/medsci14020295 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Medical Sciences, online erschienen am 06.06.2026. Verfasst von Maximilian Vlad Muntean und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic and Reconstructive Surgery, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania. Hauptthemen laut MEDLINE: Mammaplasty, Perforator Flap, Breast Neoplasms, Epigastric Arteries. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: “Iuliu Hațieganu” University of Medicine and Pharmacy Cluj-Napoca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Deep inferior epigastric perforator (DIEP) flap reconstruction represents the gold standard for autologous breast reconstruction, while profunda artery perforator (PAP) flap reconstruction has developed as a reliable alternative, particularly in patients with low body mass index or inadequate abdominal tissue. Even though several comparative studies have evaluated surgical and patient-reported outcomes between PAP and DIEP flaps, evidence regarding reconstructive timing, oncologic safety, and interactions with adjuvant therapies remains scarce, especially for PAP reconstruction.

Methods

A narrative review of the literature was conducted using PubMed. Studies assessing PAP and DIEP flap breast reconstruction were included, with particular focus on surgical outcomes, patient-reported outcomes, reconstructive timing (immediate or delayed reconstruction), oncologic safety, recurrence, and the effects of radiotherapy and chemotherapy. Comparative studies, cohort studies, systematic reviews, and meta-analyses were synthesized through a narrative review.

Results

Twenty studies were included. Comparative evidence showed similar flap survival rates and overall patient satisfaction between the two methods, with flap success rates approaching 98–100%. PAP reconstruction was associated with increased donor-site wound complications and, in some studies, increased fat necrosis rates, while long-term patient-reported and aesthetic outcomes remained equivalent between techniques. In contrast to the relatively limited PAP literature, DIEP reconstruction has been widely studied in terms of reconstructive timing and oncologic safety. Current evidence indicates that immediate DIEP reconstruction does not increase the risk of flap loss, major complications, or recurrence in comparison with delayed reconstruction and might optimize early postoperative recovery and patient-reported outcomes. Nevertheless, none of the identified studies directly compared PAP and DIEP reconstruction with respect to immediate versus delayed timing, exposure to radiotherapy or chemotherapy, or long-term oncologic outcomes.

Conclusions

PAP flap appears to represent a reliable alternative to DIEP flap reconstruction. However, major gaps in the literature persist involving PAP reconstruction in oncologic and timing-related settings. Future prospective multicenter studies that directly compare PAP and DIEP flaps according to reconstructive timing, exposure to adjuvant therapy, recurrence, and patient-reported outcomes are warranted to establish evidence-based reconstructive strategies for oncologic breast reconstruction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MammaplastyPerforator FlapBreast NeoplasmsEpigastric ArteriesHumansFemale

Stichwörter der Autor:innen

DIEP flapPAP flapbreast reconstructiononcologic outcomesreconstructive timing

Autor:innen und Institutionen

  • Department of Plastic and Reconstructive Surgery, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
  • Department of Plastic Surgery, "Prof. Dr. Ion Chiricuță" Institute of Oncology, 400015 Cluj-Napoca, Romania.
  • Faculty of Medicine, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
  • Department of Oncological Surgery and Gynecological Oncology, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
  • Department of Surgical Oncology, "Prof. Dr. Ion Chiricuță" Institute of Oncology, 400015 Cluj-Napoca, Romania.
  • Department of Surgery, Ponderas Academic Hospital, 014142 Bucharest, Romania.

ORCID-Profile: Vlad Alexandru Gâta, Ștefan Țîțu, Ioan Constantin Pop, Alex Victor Orădan, Roxana Pintican, Nicoleta Zenovia Antone, Patriciu Andrei Achimaș-Cadariu

Förderung

  • “Iuliu Hațieganu” University of Medicine and Pharmacy Cluj-Napoca

Zitieren

APA

Muntean, M. V., Ilieș, R. A., Gâta, V. A., Țîțu, Ș., Pop, I. C., Orădan, A. V., Filip, G. G., Pintican, R., Antone, N. Z., & Achimaș-Cadariu, P. A. (2026). PAP Versus DIEP Flap Breast Reconstruction: Current Evidence and the Unresolved Question of Timing and Oncologic Safety—A Narrative Review. Medical Sciences, 14(2), 295. https://doi.org/10.3390/medsci14020295

Vancouver

Muntean MV, Ilieș RA, Gâta VA, Țîțu Ș, Pop IC, Orădan AV, et al. PAP Versus DIEP Flap Breast Reconstruction: Current Evidence and the Unresolved Question of Timing and Oncologic Safety—A Narrative Review. Medical Sciences. 2026;14(2):295. doi:10.3390/medsci14020295

BibTeX
@article{Muntean2026,
  author = {Muntean, Maximilian Vlad and Ilieș, Radu Alexandru and Gâta, Vlad Alexandru and Țîțu, Ștefan and Pop, Ioan Constantin and Orădan, Alex Victor and Filip, Gerald Gheorghe and Pintican, Roxana and Antone, Nicoleta Zenovia and Achimaș-Cadariu, Patriciu Andrei},
  title = {PAP Versus DIEP Flap Breast Reconstruction: Current Evidence and the Unresolved Question of Timing and Oncologic Safety—A Narrative Review},
  journal = {Medical Sciences},
  year = {2026},
  volume = {14},
  number = {2},
  pages = {295},
  doi = {10.3390/medsci14020295}
}
Kostenlos starten →